| 1 |
34826159 | Mechanism of sensitivity to cisplatin, docetaxel, and 5-fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression. | 2022 Feb |
3 |
| 2 |
31629959 | Identification of urinary candidate biomarkers of cisplatin-induced nephrotoxicity in patients with carcinoma. | 2020 Jan 6 |
1 |
| 3 |
30146065 | Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15. | 2018 Sep 15 |
2 |
| 4 |
25590623 | Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage. | 2015 |
2 |
| 5 |
26018318 | Twist promotes invasion and cisplatin resistance in pancreatic cancer cells through growth differentiation factor 15. | 2015 Sep |
4 |
| 6 |
10506617 | Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. | 1999 Oct |
1 |